291 related articles for article (PubMed ID: 21214557)
1. Purinergic signalling at the plasma membrane: a multipurpose and multidirectional mode to deal with amyotrophic lateral sclerosis and multiple sclerosis.
Amadio S; Apolloni S; D'Ambrosi N; Volonté C
J Neurochem; 2011 Mar; 116(5):796-805. PubMed ID: 21214557
[TBL] [Abstract][Full Text] [Related]
2. Membrane compartments and purinergic signalling: P2X receptors in neurodegenerative and neuroinflammatory events.
Apolloni S; Montilli C; Finocchi P; Amadio S
FEBS J; 2009 Jan; 276(2):354-64. PubMed ID: 19076216
[TBL] [Abstract][Full Text] [Related]
3. Membrane compartments and purinergic signalling: the purinome, a complex interplay among ligands, degrading enzymes, receptors and transporters.
Volonté C; D'Ambrosi N
FEBS J; 2009 Jan; 276(2):318-29. PubMed ID: 19076212
[TBL] [Abstract][Full Text] [Related]
4. ALS: focus on purinergic signalling.
Volonté C; Apolloni S; Carrì MT; D'Ambrosi N
Pharmacol Ther; 2011 Oct; 132(1):111-22. PubMed ID: 21704075
[TBL] [Abstract][Full Text] [Related]
5. Purinergic signalling: from normal behaviour to pathological brain function.
Burnstock G; Krügel U; Abbracchio MP; Illes P
Prog Neurobiol; 2011 Oct; 95(2):229-74. PubMed ID: 21907261
[TBL] [Abstract][Full Text] [Related]
6. Purinergic contribution to amyotrophic lateral sclerosis.
Volonté C; Apolloni S; Parisi C; Amadio S
Neuropharmacology; 2016 May; 104():180-93. PubMed ID: 26514402
[TBL] [Abstract][Full Text] [Related]
7. Purinergic signalling--an overview.
Burnstock G
Novartis Found Symp; 2006; 276():26-48; discussion 48-57, 275-81. PubMed ID: 16805422
[TBL] [Abstract][Full Text] [Related]
8. Membrane compartments and purinergic signalling: occurrence and function of P2X receptors in lung.
Barth K; Kasper M
FEBS J; 2009 Jan; 276(2):341-53. PubMed ID: 19076210
[TBL] [Abstract][Full Text] [Related]
9. The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis.
Rossi S; Bernardi G; Centonze D
Exp Neurol; 2010 Jul; 224(1):92-102. PubMed ID: 20353778
[TBL] [Abstract][Full Text] [Related]
10. New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2.
Baraldi PG; Romagnoli R; Tabrizi MA; Bovero A; Preti D; Fruttarolo F; Moorman AR; Borea PA
Farmaco; 2005 Mar; 60(3):185-202. PubMed ID: 15784237
[TBL] [Abstract][Full Text] [Related]
11. Purinergic signalling in epithelial ion transport: regulation of secretion and absorption.
Novak I
Acta Physiol (Oxf); 2011 Jul; 202(3):501-22. PubMed ID: 21073662
[TBL] [Abstract][Full Text] [Related]
12. Rethinking purinergic concepts and updating the emerging role of P2X7 and P2X4 in amyotrophic lateral sclerosis.
Volonté C; Amadio S
Neuropharmacology; 2022 Dec; 221():109278. PubMed ID: 36202258
[TBL] [Abstract][Full Text] [Related]
13. Novel insights into how purines regulate pituitary cell function.
Rees DA; Scanlon MF; Ham J
Clin Sci (Lond); 2003 May; 104(5):467-81. PubMed ID: 12578557
[TBL] [Abstract][Full Text] [Related]
14. Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future.
Burnstock G
Bioessays; 2012 Mar; 34(3):218-25. PubMed ID: 22237698
[TBL] [Abstract][Full Text] [Related]
15. Introduction to Purinergic Signaling.
Burnstock G
Methods Mol Biol; 2020; 2041():1-15. PubMed ID: 31646477
[TBL] [Abstract][Full Text] [Related]
16. Introductory overview of purinergic signalling.
Burnstock G
Front Biosci (Elite Ed); 2011 Jun; 3(3):896-900. PubMed ID: 21622101
[TBL] [Abstract][Full Text] [Related]
17. Involvement of P2 receptors in the growth and survival of neurons in the CNS.
Franke H; Illes P
Pharmacol Ther; 2006 Mar; 109(3):297-324. PubMed ID: 16102837
[TBL] [Abstract][Full Text] [Related]
18. ATP and the pathogenesis of COPD.
Mortaz E; Folkerts G; Nijkamp FP; Henricks PA
Eur J Pharmacol; 2010 Jul; 638(1-3):1-4. PubMed ID: 20423711
[TBL] [Abstract][Full Text] [Related]
19. An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration.
Burnstock G
Neuropharmacology; 2016 May; 104():4-17. PubMed ID: 26056033
[TBL] [Abstract][Full Text] [Related]
20. Purinergic signaling in Alzheimer's disease.
Erb L; Woods LT; Khalafalla MG; Weisman GA
Brain Res Bull; 2019 Sep; 151():25-37. PubMed ID: 30472151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
